SEC Form 4 · accession 0001490476-26-000002
DiaMedica Therapeutics Inc. · DMAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Kellen
Officer — CFO & Secretary
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 5:23 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001401040
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.84 | Jun 1, 2026 | A | 162,000 | A | — | Jun 1, 2036 | Voting Common Shares | 162,000 | 162,000 | D |
Explanation of responses
- F1Scheduled to vest with respect to 25% of the shares on the one-year anniversary of the grant date, with the remaining shares scheduled to vest in twelve equivalent quarterly installments.